1. Home
  2. DNLI vs VSCO Comparison

DNLI vs VSCO Comparison

Compare DNLI & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • VSCO
  • Stock Information
  • Founded
  • DNLI 2013
  • VSCO 1977
  • Country
  • DNLI United States
  • VSCO United States
  • Employees
  • DNLI N/A
  • VSCO N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • VSCO Clothing/Shoe/Accessory Stores
  • Sector
  • DNLI Health Care
  • VSCO Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • VSCO Nasdaq
  • Market Cap
  • DNLI 2.1B
  • VSCO 2.1B
  • IPO Year
  • DNLI 2017
  • VSCO N/A
  • Fundamental
  • Price
  • DNLI $15.42
  • VSCO $29.15
  • Analyst Decision
  • DNLI Strong Buy
  • VSCO Hold
  • Analyst Count
  • DNLI 15
  • VSCO 12
  • Target Price
  • DNLI $33.50
  • VSCO $26.50
  • AVG Volume (30 Days)
  • DNLI 2.1M
  • VSCO 2.5M
  • Earning Date
  • DNLI 11-05-2025
  • VSCO 08-28-2025
  • Dividend Yield
  • DNLI N/A
  • VSCO N/A
  • EPS Growth
  • DNLI N/A
  • VSCO 6.76
  • EPS
  • DNLI N/A
  • VSCO 1.86
  • Revenue
  • DNLI N/A
  • VSCO $6,265,000,000.00
  • Revenue This Year
  • DNLI N/A
  • VSCO $3.84
  • Revenue Next Year
  • DNLI $95,463.19
  • VSCO $2.44
  • P/E Ratio
  • DNLI N/A
  • VSCO $15.67
  • Revenue Growth
  • DNLI N/A
  • VSCO 2.29
  • 52 Week Low
  • DNLI $10.57
  • VSCO $13.76
  • 52 Week High
  • DNLI $33.33
  • VSCO $48.73
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 62.72
  • VSCO 69.15
  • Support Level
  • DNLI $12.58
  • VSCO $25.09
  • Resistance Level
  • DNLI $15.75
  • VSCO $27.93
  • Average True Range (ATR)
  • DNLI 0.68
  • VSCO 1.18
  • MACD
  • DNLI 0.24
  • VSCO 0.16
  • Stochastic Oscillator
  • DNLI 89.59
  • VSCO 82.69

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.

Share on Social Networks: